Inxmed co. ltd
WebNANJING, China, April 14, 2024 -- InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy … WebDiscovery Company profile page for Inxmed (Nanjing) Co., Ltd including technical research,competitor monitor,market trends,company profile& stock symbol
Inxmed co. ltd
Did you know?
Web8 mei 2024 · NANJING, China, May 8, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies t... WebNANJING, China, May 9, 2024 -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug resistance for hard-to-treat solid tumors, today announced that it had completed $15 million in Series B+ Financing. The Series B+ was funded by Hyfinity Investments. 14
Web18 okt. 2024 · InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting drug resistance for hard-to-treat solid tumors, … WebDiscovery Company profile page for Fuzhou Jinhui Health Technology Co., Ltd. including technical research,competitor monitor,market trends,company profile& stock symbol
Web14 apr. 2024 · InxMed Co., Ltd. announced that IN0018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China … WebInxMed General Information. Description. Developer of cancer therapeutics. The company currently has pharmaceuticals targeting pancreatic, ovarian, gastric and other forms of …
WebInxMed (Hong Kong) Limited. InxMed (Hong Kong) Limited (CR No: 2347788) was incorporated on 11-MAR-2016 in Hong Kong. Their business is recorded as Private …
Web7 sep. 2024 · NANJING, China, Sept. 7, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicates to developing innovative therapies targeting … grant thornton uk annual accountsWebInxmed Co. Ltd. has raised $50 million in a series B round to support clinical trials of its lead candidate, IN-10018, for the treatment of multiple cancers in both the U.S. and … grant thornton uk business risk servicesgrant thornton uk auditWebThe company was founded in 2024 and is based in Beijing, China. Headquarters Location 3007, 30th Floor, Block 2, China Central Place Office Building, No.79 Jianguo Road, … chipotle echo parkWeb9 mei 2024 · InxMed is a clinical-stage biotech company established in the end of 2024. The company dedicates on developing innovative therapies targeting stroma … grant thornton uganda careersWeb26 sep. 2024 · November 17, 2024 updated by: InxMed (Shanghai) Co., Ltd. A Phase Ib, Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and … chipotle e coli outbreak articleWeb邮箱： [email protected] 公司地址： 南京市江北新区探秘路73号树屋十六栋D-2栋3层 grant thornton uk corporate finance